The 300B Question — A Legacy Lounge· IP Edition (panel+dinner)
An evening on intellectual property, applied longevity, and the architecture of lasting value.
$300 billion, that is the size of the branded drug revenue staring down patent expiration between 2025 and 2030 — the largest patent cliff in modern history. Add eighteen months of AI commoditizing software, the next wave already coming for data tooling and vertical SaaS, and a digital-health sector racing to lock in regulatory and data moats before models close the window.
One question is suddenly louder than every other question in venture: who inherits the next decade of IP-led enterprise value across longevity, AI infrastructure, and digital health?
Agenda
5:00 PM — Networking (beverage + refreshments provided)
5:30 PM — Fireside: The 300B Question, Q&A.
7:00 PM — Dinner for all approved attendees
Featured speakers
Chima Osuka,Senior Venture Partner
Works at Suncoast Ventures, bringing deep expertise in healthcare investing, portfolio innovation, and building a strong founder-investor network.
Ryan Green, Head of portfolio, Antler US
He is helping grow one of the world’s most active early-stage VC globally. As a proud Legacy Lounge community partner, Ryan looks to find what makes an AI founder truly fundable before diligence arrives.
Fredrick Tsang, Attorney| IP Strategy Expert
Works with venture-backed companies on patent strategy, IP positioning, AI, and life sciences.
Steve Duddy, Mentor|Draper university & Executive Advisor
20+ years across medtech, pharma, life sciences, commercialization, fundraising, and growth.
Dr. Prasun Mishra
Chairman, WISE fund. Serial entrepreneur, investor, and advisor. A globally recognized life sciences and healthcare leader, renowned for his contributions to drug development, precision medicine, and biotech innovation through roles at organizations including Genentech, Roche, NIH, NCI, and the U.S. Department of Health and Human Services
Moderator: Teresa Ge
Founder, Succedia Ventures & Host of Legacy Lounge
Invests and leads top scientists, founders and technologists in applied longevity to bring top IPs to the market.
Who's in the room
Legacy Lounge Past rooms have included VP from NVIDIA, leading scientists from Stanford Health; family office/ VC Managing partners.
The IP Edition is curated specifically around Series seed–A founders building IP-defensible companies. Investors and family-office investors seeking exposure to patent-led therapeutics, IP-defensible AI infrastructure, and regulated digital-health platforms.
*All applications are reviewed before approval.
Dress code: Smart casual — this is a salon, not a conference
Hosted by
Legacy Lounge is an invitation-only community founded by Teresa Ge-connecting the people building at the frontier of health, capital, and technology, powered by Succedia Ventures-an IP-led venture studio investing in applied longevity.
Berkeley Pharma Tech Foundation is a nonprofit expanding biotech understanding and industry access through education, mentorship, and community events for aspiring scientists, entrepreneurs, and innovators. To get involved, follow us on LinkedIn or reach out to Vanloan Nguyen—we’re building toward a funded research program and a state-of-the-art Bay Area biotech lab.
Antler ranked #1 by deal volume by PitchBook in 2024, with 1,800+ portfolio companies across 24 locations worldwide backs founders from day zero — before the product, before the team, before the market has named the category.
Sponsored by:
This event is sponsored by Fenwick & West-a leading global law firm providing legal services to the world's most innovative technology and life sciences companies.